BDBM218671 US9289400, ES609

SMILES CC(N)CCc1ccccc1Cl

InChI Key InChIKey=JPYONMJJWKTSBP-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 218671   

TargetSodium-dependent serotonin transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 3.59E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 293nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 8.52E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent